A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection
Completed · Phase 2 · Has a placebo group
Conditions studied: Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
In brief
This is a Phase 2, randomized, parallel-group, double-blind, placebo-controlled, 14-week study designed to evaluate the efficacy and safety of TNX-102 SL 5.6 mg (2 x 2.8 mg tablets) taken once daily at bedtime for the management of multi-site pain associated with Long COVID.
Key facts
- Study ID
- NCT05472090
- Run by
- Tonix Pharmaceuticals, Inc.
- People needed
- 63
- Starts
- 2022-08-18
- Expected to finish
- 2023-07-27
- Last updated by the study team
- 2024-11-26
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Accel Research-Birmingham Clinical Research Unit — Birmingham, Alabama, United States
- Tonix Clinical Site — Oceanside, California, United States
- Tonix Clinical Site — Santa Ana, California, United States
- Tonix Clinical Site — Centennial, Colorado, United States
- Tonix Clinical Site — Aventura, Florida, United States
- Tonix Clinical Site — Fort Myers, Florida, United States
- Tonix Clinical Site — Orlando, Florida, United States
- Tonix Clinical Site — St. Petersburg, Florida, United States
- Tonix Clinical Site — Alpharetta, Georgia, United States
- Tonix Clinical Site — Atlanta, Georgia, United States
- Tonix Clinical Site — Chicago, Illinois, United States
- Tonix Clinical Site — Des Moines, Iowa, United States
- Tonix Clinical Site — Iowa City, Iowa, United States
- Tonix Clinical Site — Prairie Village, Kansas, United States
- Tonix Clinical Site — New Orleans, Louisiana, United States
- Tonix Clinical Site — Prairieville, Louisiana, United States
- Tonix Clinical Site — Boston, Massachusetts, United States
- Tonix Clinical Site — Boston, Massachusetts, United States
- Tonix Clinical Site — Methuen, Massachusetts, United States
- Tonix Clinical Site — Gulfport, Mississippi, United States
- Tonix Clinical Site — Albuquerque, New Mexico, United States
- Tonix Clinical Site — New York, New York, United States
- Tonix Clinical Site — Williamsville, New York, United States
- Tonix Clinical Site — Shelby, North Carolina, United States
- Tonix Clinical Site — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.